Zevra Therapeutics Inc.
ZVRA
$12.01-0.41%
End of day · as of Sep 11, 2026, 6:30 PM ET
Mkt cap
$745.44M
EV/Sales
7.00
P/E ratio
N/A
FY2025 Revenue
$106.47M
EPS (TTM)
$0.93
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
78.17%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported ZVRA revenue for 2025-12-31 was $106.5M. Net income was $83.2M. Revenue was up 350.9% from 2024-12-31 to 2025-12-31. ZVRA currently screens at market cap $745.4M.
Use this ZVRA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ZVRA income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company in the Healthcare sector.
Latest cached Zevra Therapeutics Inc. (ZVRA) revenue for Dec 31, 2025 was $106.5M. Net income was $83.2M. Statements: https://lician.com/financials/zvra
Zevra Therapeutics Inc. (ZVRA) market capitalization is $745.4M on the latest cached snapshot.
Zevra Therapeutics Inc. (ZVRA) cached previous close $12.06; day range $11.96 – $12.30; volume 579,348. Session quote: https://lician.com/quote/zvra
Zevra Therapeutics Inc. (ZVRA) latest cached earnings event is "ZVRA earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings